Company profile for Amphix Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Amphix Bio is a preclinical-stage biotech pioneering supramolecular therapeutics designed to activate the body’s own regenerative programs. By instructing cells to repair and restore function lost through injury, disease, or aging, we aim to redefine regenerative medicine. Our mission is to extend healthspan—the years people live active, fulfilling lives—by developing therapies that harness biology’s innate capacity fo...
Amphix Bio is a preclinical-stage biotech pioneering supramolecular therapeutics designed to activate the body’s own regenerative programs. By instructing cells to repair and restore function lost through injury, disease, or aging, we aim to redefine regenerative medicine. Our mission is to extend healthspan—the years people live active, fulfilling lives—by developing therapies that harness biology’s innate capacity for self-renewal and healing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
400 North Aberdeen Street Suite 900 Chicago, IL 60642
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/amphix-bio-raises-12-5m-seed-round-to-advance-peptide-drug-platform-302646037.html

PR NEWSWIRE
18 Dec 2025

https://www.prnewswire.com/news-releases/amphix-bio-receives-fda-orphan-drug-designation-for-neural-regeneration-therapeutic-to-treat-acute-spinal-cord-injury-302506799.html

PR NEWSWIRE
16 Jul 2025

https://www.prnewswire.com/news-releases/amphix-bio-lands-federal-and-state-grants-to-manufacture-regenerative-therapies-302293145.html

PR NEWSWIRE
31 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty